Joshua Silverman

Joshua Silverman

Chief Executive Officer presso PHARMACYTE BIOTECH, INC.

Patrimonio netto: 237 076 $ in data 31/03/2024

53 anni
Finance
Health Technology
Consumer Services

Profilo

Joshua Nathaniel Silverman founded Iroquois Capital LP in 2002, where he is working as Chief Executive Officer from 2002, Iroquois Capital Management LLC in 2003, where he worked as Co-Chief Investment Officer & Managing Member from 2003 to 2016, and Parkfield Funding LLC in 2016, where he is working as Managing Member from 2016.
Mr. Silverman also currently works at PharmaCyte Biotech, Inc., as Chairman, President & Chief Executive Officer from 2022, Neurotrope, Inc., as Chairman from 2016, Synaptogenix, Inc., as Independent Chairman from 2016, Petros Pharmaceuticals, Inc., as Vice Chairman from 2020, AYRO, Inc., as Executive Chairman, Chief Financial Officer & CAO from 2024, MyMD Pharmaceuticals, Inc., as Chairman, Femasys, Inc., as Independent Director from 2023, Crellin Capital LLC, as Director, and Taplmmune, Inc., as Director.
Mr. Silverman also formerly worked at DropCar, Inc., as Chairman, MIRA Pharmaceuticals, Inc., as Chairman, Alanco Technologies, Inc., as Director in 2016, National Holdings Corp., as Independent Director from 2014 to 2016, WPCS International, Inc., as Director, Marker Therapeutics, Inc., as Independent Director from 2016 to 2018, Akers Biosciences, Inc., as Lead Independent Director from 2018 to 2020, MGT Capital Investments, Inc., as Independent Director from 2014 to 2016, Atrinsic, Inc., as Director, Joele Frank, Wilkinson Brimmer Katcher, as Director, JNS Holdings Corp., as Director, Protagenic Therapeutics, Inc., as Independent Non-Executive Director from 2016 to 2022, and Vertical Ventures LLC, as Co-Chief Investment Officer from 2000 to 2003.
Mr. Silverman received his undergraduate degree in 1992 from Lehigh University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
20/03/2024 50 000 ( 0.59% ) 118 500 $ 31/03/2024
27/10/2023 49 584 ( 1.01% ) 82 805 $ 31/03/2024
26/03/2024 11 238 ( 0.51% ) 16 632 $ 31/03/2024
29/03/2024 5 000 ( 0.23% ) 11 950 $ 31/03/2024
08/04/2024 38 238 ( 0.19% ) 7 189 $ 31/03/2024

Posizioni attive di Joshua Silverman

SocietàPosizioneInizio
NEUROTROPE, INC. Chairman 04/08/2016
AYRO, INC. Director of Finance/CFO 01/03/2024
PETROS PHARMACEUTICALS Director/Board Member 01/01/2020
SYNAPTOGENIX, INC. Chairman 04/08/2016
MYMD PHARMACEUTICALS, INC. Chairman -
PHARMACYTE BIOTECH, INC. Chief Executive Officer 06/10/2022
FEMASYS INC. Director/Board Member 21/11/2023
Founder 01/08/2016
Taplmmune, Inc. Director/Board Member -
░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Tutte le posizioni attive di Joshua Silverman

Precedenti posizioni note di Joshua Silverman

SocietàPosizioneFine
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Joshua Silverman

Formazione di Joshua Silverman

Lehigh University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Joshua Silverman

Relazioni

99

Relazioni di 1° grado

26

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
MARKER THERAPEUTICS, INC.

Health Technology

FEMASYS INC.

Electronic Technology

MGT CAPITAL INVESTMENTS, INC.

Technology Services

JNS HOLDINGS CORPORATION

Industrial Services

PROTAGENIC THERAPEUTICS, INC.

Health Technology

PETROS PHARMACEUTICALS

Health Technology

AYRO, INC.

Producer Manufacturing

MIRA PHARMACEUTICALS, INC.

Health Technology

Aziende private17

Industrial Services

Finance

Consumer Services

Health Technology

Finance

Health Technology

Finance

Commercial Services

Finance

PharmaCyte Biotech, Inc.

Commercial Services

Synaptogenix, Inc.

Finance

Finance

Consumer Services

MyMD Pharmaceuticals, Inc.

Taplmmune, Inc.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Joshua Silverman